Integrating Traditional and Modern Knowledge: A Review on Khulanjan (Alpinia galanga) in Unani Medicine
Abstract
Aims and objective: Khulanjan (Alpinia galanga) is a rhizomatous Zingiberaceae herb long used in Unani medicine. Classical texts ascribe to Khulanjan a warm, dry temperament (Unani mizāj) and describe it as a carminative digestive stimulant and tonic (e.g. Mufarreh, Muqawwi-e-Meda, Muqawwi-e-Qalb), with expectorant and cardiac tonic actions. The objectives of this review are to examine and correlate these traditional Unani uses of khulanjan with modern pharmacological findings; to bridge classical knowledge and contemporary science; and to identify potential therapeutic applications of its bioactive constituents. These traditional uses for indigestion, flatulence, respiratory complaints and weakness reflect its characterization as an aromatic, stimulant herb. Modern phytochemical analyses identify key bioactive constituents in Khulanjan rhizome, including the flavonoid galangin and volatile oils rich in 1,8-cineole, β-pinene, methyl cinnamate, borneol and related terpenes. Such compounds confer demonstrable bioactivities: experimental studies report strong antioxidant, anti-inflammatory and broad-spectrum antimicrobial effects of A. galanga extracts. For example, high phenolic/flavonoid content in the rhizome correlates with potent radical‐scavenging and antibacterial activity in vitro. Thus, contemporary research largely validates classical claims: Khulanjan’s traditional designation as a digestive/carminative tonic and healer of ‘phlegm’ and inflammation finds support in its phytochemistry and observed pharmacology. This synthesis of Unani doctrine and modern evidence underscores that the age-old uses of Khulanjan have a rational basis, illustrating how classical herbal wisdom aligns with scientific pharmacological validation.
Keywords: Alpinia galanga; Khulanjan; Unani medicine; Mizaj; phytochemicals; antioxidant; anti-inflammatory; antimicrobial.
Keywords:
Alpinia galanga, Khulanjan, Unani medicine, Mizaj, phytochemicals, antioxidant, anti-inflammatory, antimicrobialDOI
https://doi.org/10.22270/jddt.v15i11.7443References
1. Fahamiya N, Shiffa M, Miriyalilini P. Khulanjan (Alpinia galanga) from the perspective of unani medicine. Int J Sci Innov Discov. 2018; 5:2319-8141.
2. Noman M, Parveen U, Khan UA, Kabir H. A review on khulanjan (Alpinia galanga) with special reference to Unani medicine. Int J Botany Studies. 2020;5(5):213 217. https://www.botanyjournals.com/assets/archives/2020/vol5issue5/5-4-102-620.pdf
3. Shetty GR, Monisha S. Pharmacology of an endangered medicinal plant Alpinia galanga – a review. Res J Pharm Biol Chem Sci. 2015;6(1):60 67.
4. Eram S, Mujahid M, Bagga P, Ahmad MA, Akhter MS, Kumar A, Ahsan F. A review on phytopharmacological activity of Alpinia galanga. Int J Pharm Pharm Sci. 2019;11(3):6 11. https://doi.org/10.22159/ijpps.2019v11i3.31352
5. Chouni A, Paul S. A review on phytochemical and pharmacological potential of Alpinia galanga. Pharmacogn J. 2018;10(1):9 15. https://doi.org/10.5530/pj.2018.1.2
6. Verma RK, Sharma N. Phytochemical and pharmacological activities of Alpinia galanga – a review. Asian J Pharm Pharmacol. 2022;8(3):74 85. https://doi.org/10.31024/ajpp.2022.8.3.3
7. Babu SS, Thomas VP, Thomas BT. Phytochemistry, pharmacology and ethnobotany of Alpinia malaccensis and Alpinia galanga. Int J Plant Environ. 2024;10(3):16 24.
8. Tanaka, K., Koga, T., Yamaguchi, T. & Okuno, Y. (2020) ‘Pharmacological effects of 1′-acetoxychavicol acetate, a major constituent in Alpinia galanga and Alpinia conchigera’, Journal of Medicinal Food, 23(9), pp. 754-763. https://doi.org/10.1089/jmf.2019.4590
9. McBride, M., Gill, D. & Williams, K. (2023) ‘Galangin: a promising flavonoid for the treatment of rheumatoid arthritis’, Frontiers in Pharmacology, 14:11279697. https://doi.org/10.3389/fphar.2023.12279697
10. Ganeshpurkar, A. & Saluja, A.K. (2017) ‘The pharmacological potential of galangin’, Pharmacognosy Reviews, 11(22), pp. 133-137. https://doi.org/10.4103/phrev.phrev_21_17
11. Song B, Niu W, Zhang S, Hao M, Li Y, Chen Q, Li S, Tong C. A mechanistic review of the pharmacological aspects of Kaempferide as a natural compound. Heliyon. 2024 Oct 15;10(19).
12. Zheng CM, Lu KC, Chen YJ, Li CY, Lee YH, Chiu HW. Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy. Biomedicine & Pharmacotherapy. 2022 Oct 1; 154:113565.https://doi.org/10.1016/j.biopha.2022.113565
13. Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R, Vetter H. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respiratory medicine. 2003 Mar 1;97(3):250-6. PMID 12645832
14. Juergens UR. Anti-inflammatory properties of the monoterpene 1.8-cineole: current evidence for co-medication in inflammatory airway diseases. Drug research. 2014 Dec;64(12):638-46. https://doi.org/10.1055/s-0034-1372609
15. Nisar MF, Khadim M, Rafiq M, Chen J, Yang Y, Wan CC. Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review. Oxid Med Cell Longev. 2021 Aug 3; 2021:2497354. https://doi.org/10.1155/2021/2497354. PMID: 34394824; PMCID: PMC8357497.
16. Shahina Z, Dahms TE. A comparative review of eugenol and citral anticandidal mechanisms: Partners in crimes against fungi. Molecules. 2024 Nov 23;29(23):5536.. https://doi.org/10.3390/molecules29235536
17. Subash KR, Prakash BG. In vitro anti oxidant studies on ethanolic extract of Alpinia galanga. Int J Basic Clin Pharmacol. 2016;5(3):960 964. https://doi.org/10.18203/2319 2003.ijbcp20161868
18. Subash KR, Britto GF, Kumar KS, Umamaheshwari A, Konda VC, Prakash BG. Analgesic activity of Alpinia galanga extract in mice models and TNF-alpha receptor computational docking analysis on its leads with pharmacokinetics prediction. Int J Basic Clin Pharmacol. 2018 Mar;7(3):446-50.
19. Shiffa M, Kazmi MH, Ali SM, Anwar A, Yasir M, Fahamiya N, Haque MM. In Vitro and In Vivo Anti-Inflammatory Activity of a Combination of Extracts from Cinnamomum zeylanicum, Alpinia galanga, and Withania somnifera used in Unani Medicine. Altern Ther Health Med. 2024 May;30(5):6-13. PMID: 38581340.https://pubmed.ncbi.nlm.nih.gov/38581340/
20. Sam D, Knox S, Asharaf S, BN A, VP S. Phytochemical Profiling and Evaluation of Antibacterial, Antifungal, and Antiproliferative Activities of Alpinia galanga Rhizome Extracts.
21. Revathi VM, Anuradha G, Sumathy S. An In vitro evaluation of antidiabetic activity of Alpinia galangal and Alpinia calcarata. Journal of Pharmaceutical Research International. 2021 Dec 14;33(57B):28-35.https://doi.org/10.9734/jpri/2021/v33i57B34025
22. Jenie R, Santoso R, Salsabila I, Nugraheni N, Meiyanto E. Alpinia galanga extract induces senescence in HER2-overexpressing breast cancer cells. Thai Journal of Pharmaceutical Sciences (TJPS). 2021 Jan 13;45(1).
23. Simon A, Nghiem KS, Gampe N, Garádi Z, Boldizsár I, Backlund A, Darcsi A, Nedves AN, Riethmüller E. Stability Study of Alpinia galanga Constituents and Investigation of Their Membrane Permeability by ChemGPS-NP and the Parallel Artificial Membrane Permeability Assay. Pharmaceutics. 2022 Sep 18;14(9):1967. https://doi.org/10.3390/pharmaceutics14091967. PMID: 36145715; PMCID: PMC9502528.
24. Ibn Sina. Al-Qānūn fī al-Ṭibb [The Canon of Medicine]. Vol. II–V. New Delhi: Idara Kitab-us-Shifa. Reprint ed. 2010. p. 45, 121, 214
25. Najmul Ghani and Hakim Mohammed. Makhzan al-Advia. Vol. II–III. New Delhi: Idara Kitab-us-Shifa. Reprint ed. 2011. p. 233, 432
26. Central Council for Research in Unani Medicine (CCRUM). National Formulary of Unani Medicine (NFUM). Part I & II. New Delhi: Ministry of AYUSH, Government of India; 2006–2011. p. 72, 145
27. Al-Bīrūnī, Abū Rayhān. Kitāb al-Saydanah fī al-Tibb. New Delhi: CCRUM; 2001. p. 289
28. National Formulary of Unani Medicine: Central Council for Research in Unani Medicine Delhi, First edition. Part VI, 2011. p. 60, 61, 66
29. National Formulary of Unani Medicine: Central Council for Research in Unani Medicine Delhi, Part VI, 2011. p. 86,87
Published
Abstract Display: 263 
PDF Downloads: 162 PDF Downloads: 48 How to Cite
Issue
Section
Copyright (c) 2025 Mohammed Wasim Ahmed, Safder Husain , Reesha Ahmed , Ziaul Haq Siddiqui
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.